|
Basic Characteristics of Mutations
|
|
Mutation Site
|
H520Q |
|
Mutation Site Sentence
|
Characterization of a ganciclovir-resistant cytomegalovirus strain from a patient with AIDS showed a histidine-to-glutamine change at residue 520 of UL97 (Q520 mutation). |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
UL97 |
|
Standardized Encoding Gene
|
UL97
|
|
Genotype/Subtype
|
- |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
HCMV-HIV Coinfeciton
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
- |
|
Treatment
|
ganciclovir |
|
Location
|
- |
|
Literature Information
|
|
PMID
|
7625819
|
|
Title
|
Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir
|
|
Author
|
Hanson MN,Preheim LC,Chou S,Talarico CL,Biron KK,Erice A
|
|
Journal
|
Antimicrobial agents and chemotherapy
|
|
Journal Info
|
1995 May;39(5):1204-5
|
|
Abstract
|
Characterization of a ganciclovir-resistant cytomegalovirus strain from a patient with AIDS showed a histidine-to-glutamine change at residue 520 of UL97 (Q520 mutation). In anabolism studies, Q520 was associated with impaired phosphorylation of ganciclovir. Transfer of Q520 to a recombinant virus resulted in a ganciclovir-resistant phenotype.
|
|
Sequence Data
|
-
|